논문KCI 등재
임신성 당뇨병의 최신 지견
Recent advances in gestational diabetes mellitus
대한산부인과학회 (Korean Soceity of Obstetrics and Gynecology)|2007.11|Obstetrics & Gynecology Science|제50권 제11호|pp. 1445-1454
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
주제분류산부인과학
초록
=최근 가임기 여성에서 비만 인구가 증가하고, 식이나 생활 습관의 변화에 따라 제 2형 당뇨병이나 임신성 당뇨병의 유병율이 증가하고 있다. 임신성 당뇨병은 임신 중에 처음 발견되거나 시작되는 불내당능이 특징으로, 혈당 조절 정도에 따라 주산기 예후에 영향을 미치고 합병증이 증가하므로 조기 발견 및 치료가 중요하다. 또한, 임신성 당뇨병의 기왕력은 다음 임신에서도 재발하거나 추후에 제 2형 당뇨병으로 이환될 위험성이 높기 때문에 출산 후에도 지속적인 추적 관찰이 필요하다.
참고문헌 (79)
- American Diabetes Association, "Gestational diabetes mellitus", 23, pp.77~79 (2000)
- Cousins L, "Screening recommendations for gestational diabetes mellitus", pp.493~6
- O’Sullivan JB, "Screening criteria for high-risk gestational diabetic patients", pp.895~900
- Maresh M, "Screening for gestational diabetes mellitus", 10, pp.317~323 (2005)
- Antenatal Care, "National Collaborating Centre for Women’s and Children’s Health Routine Care for the Healthy Pregnant Woman London Royal College of Obstetricians and Gynaecology" (1993)
- "Gestational diabetes mellitus", 26, pp.103~105 (2003)
- Weiner CP, "Cost efficacy of routine screening for diabetes in pregnancy", pp.1 255~9
- Perucchini D, "Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study", 319, pp.812~815 (1999)
- Kousta E, "IImplications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes", 22, pp.933~937 (1999)
- Cousins L, "Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy", pp.455~60
- Grandjean H, "Detection of gestational diabetes by means of ultrasonic diagnosis of excessive fetal growth", pp.790~2
- Scott DA, "Screening for gestational diabetes: a systematic review and economic evaluation", 6, pp.1~161 (2002)
- Carpenter MW, "Criteria for screening tests for gestational diabetes", pp.768~73
- National Diabetes Data Group, "Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance", pp.1039~57
- Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", 15, pp.539~553 (1998)
- Fourlanos S, "A clinical screening tool identifies autoimmune diabetes in adults", 29, pp.970~975 (2006)
- Di Cianni G, "Intermediate metabolism in normal pregnancy and in gestational diabetes", 19, pp.259~270 (2003)
- Lapolla A, "therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?", 21, pp.241~252 (2005)
- Buchanan TA, "Gestational diabetes mellitus", 115, pp.485~491 (2005)
- Petersen JS, "GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy", 39, pp.1329~1333 (1996)
- Weng J, "Screening for MODY mutations, GAD antibodies, and type 1 diabetes?. associated HLA genotypes in women with gestational diabetes mellitus", 25, pp.68~71 (2002)
- Mauricio D, "Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy", pp.237~41
- Jarvela IY, "Gestational diabetes idenitifies women at risk for permanent type 1 and type 2 diabetes in fertile age", 29, pp.607~612 (2006)
- Kousta E, "Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes", 18, pp.683~684 (2001)
- Saker PJ, "High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population", 39, pp.1325~1328 (1996)
- Chen Y, "Mitochondrial gene mutations in gestational diabetes mellitus", 48, pp.29~35 (2000)
- Xiang AH, "Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus", 48, pp.848~854 (1999)
- Catalano PM, "Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes", 180, pp.903~916 (1999)
- Kautzky-Willer A, "Increased plasma leptin in gestational diabetes", 44, pp.164~172 (2001)
- Winkler G, Cseh K, Baranyi ?, Melczer Z, Speer G, Haj?s P, et al, "Tumor necrosis factor system and insulin resistance in gestational diabetes", 56, pp.93~99 (2002)
- Retnakaran R, "C-reactive protein and gestational diabetes: the central role of maternal obesity.", 88, pp.3507~3512 (2003)
- Retnakaran R, "Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes", 27, pp.799~800 (2004)
- Tiikkainen M, "Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes", 10, pp.859~867 (2002)
- Kautzky-Willer A, "Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes", 52, pp.244~251 (2003)
- Kjos SF, "Gestational diabetes mellitus", 341, pp.1749~1756 (1999)
- Tuffnell DJ, "Treatments for gestational diabetes and impaired glucose tolerance in pregnancy", 2, pp.CD003395~ (2005)
- Naylor CD, "Cesarean delivery in relation to birth weight and gestational glucose tolerance. Pathophysiology or practice style?", 275, pp.1165~1170 (1996)
- Lu GC, "The impact of lower threshold values for the detection of gestational diabetes mellitus", 95, pp.S44~ (2000)
- Essel JK, "Macrosomia-maternal and fetal risk factors", 85, pp.43~46 (1995)
- Casey BM, "Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population", 90, pp.869~873 (1997)
- Ecker JL, "Birth weight as a predictor of brachial plexus injury", 89, pp.643~647 (1997)
- Perlow JH, "Birth trauma. A five-year review of incidence and associated perinatal factors", 41, pp.754~760 (1996)
- Jevitt CM, "Shoulder dystocia: etiology, common risk factors, and management", 50, pp.485~497 (2005)
- Rouse DJ, "effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound", 276, pp.1480~1486 (1996)
- Ogata ES, "Perinatal morbidity in offspring of diabetic mothers", 3, pp.652~657 (1995)
- Jensen DM, "Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile", 17, pp.281~286 (2000)
- Fraser RB, "Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycaemia", 16, pp.568~572 (1999)
- "Neurological findings at follow up in neonatal hypoglycemia", pp.629~34
- Joffe GM, "The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women", 174, pp.1032~1037 (1998)
- Nachum Z, "Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial", 319, pp.1223~1227 (1999)
- Carr DB, "Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes", 29, pp.2078~2083 (2006)
- O’Sullivan JB, "Criteria for the oral glucose tolerance test in pregnancy", pp.278~85
- Catalano PM, "Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes", pp.914~9
- Silva JK, "Ethnic differences in perinatal outcome of gestational diabetes mellitus", 29, pp.2058~2063 (2006)
- Lobner K, "Predictors of postpartum diabetes in women with gestational diabetes", 55, pp.792~770 (2006)
- Pettitt DJ, "Abnormal glucose tolerance during pregnancy in Pima Indian women long-term effects on offspring", k(wler wc), pp.126~30
- Rizzo T, "Correlations between antepartum maternal metabolism and intelligence of offspring", pp.911~6
- Crowther CA, "Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group: Effect of treatment of gestational diabetes on pregnancy outcomes", 352, pp.2477~2486 (2005)
- de Veciana M, "Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy", 333, pp.1237~1241 (1995)
- Metzger BE, "Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus", 21, pp.B161~B167 (1998)
- Turok DK, "Management of gestational diabetes mellitus", 68, pp.1769~1772 (2003)
- Rizzo T, "Correlations between antepartum maternal metabolism and child intelligence", pp.911~6
- Clapp JF 3rd, "Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women", 21, pp.B107~B120 (1998)
- Knopp RH, "Metabolic effects of hypocaloric diets in the management of gestational diabetes", pp.~71
- Pettitt DJ, "Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus", 26, pp.183~186 (2003)
- Jovanovic L, "Metabolic and immunologic effects of insulin lispro in gestational diabetes", 22, pp.1422~1427 (1999)
- Jovanovic L, "Achieving euglycaemia in women with gestational diabetes: current options for screening diagnosis and treatment", 64, pp.1401~1417 (2004)
- Homko CJ, "Insulins and oral hypoglycemic agents in pregnancy", 19, pp.679~686 (2006)
- Langer O, "comparison of glyburide and insulin in women with gestational diabetes mellitus", 343, pp.1134~1138 (2000)
- Kremer CJ, "Glyburide for the treatment of gestational diabetes", 190, pp.1438~1439 (2004)
- Chmait R, "Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus", 24, pp.617~622 (2004)
- Jacobson GF, "Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization", 193, pp.118~124 (2005)
- Glueck CJ, "Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome", 77, pp.520~525 (2002)
- Glueck CJ, "Height, weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy", 19, pp.1323~1330 (2004)
- American Diabetes Association, "Gestational diabetes mellitus (Position Statement)", 29, pp.S88~S90 (2004)
- Moses RG, "The recurrence rate of gestational diabetes in subsequent pregnancies", 19, pp.1348~1350 (1996)
- MacNeill S, "Rates and risk factors for recurrence of gestational diabetes", 24, pp.659~662 (2001)
- Diabetes Prevention Program Research Group, "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", 346, pp.393~403 (2002)
- Hamman RF, "Effect of weight loss with lifestyle intervention on risk of diabetes", 29, pp.2102~2107 (2006)
관련 논문AI추천
임신성 당뇨병 선별검사 시점 및 HbA1c 농도와 신생아의 예후와의 관계강지민, 김소영, 빈중현, 성인경, 이원배, 이정현, 이현승, 전정식, 최윤정대한진단검사의학회 · Annals of Laboratory Medicine2009 · 제29권 제2호임신중당뇨병 임부의 유병률 및 의료이용 추이강희선, 이한주, 현명선한국모자보건학회 · 한국모자보건학회지2010 · 제14권 제2호임신성 당뇨 진단 기준의 고찰김행수, 서성석, 안상태, 양성천, 양정인, 유희석, 이희종대한산부인과학회 · Obstetrics & Gynecology Science2002 · 제45권 제11호한국인에서 임신성 당뇨병의 진단적 100 gm경구 당 부하 검사의 진단 기준의 비교김경태, 김승룡, 안유헌, 이재규, 이정한, 이홍주, 황정혜대한산부인과학회 · Obstetrics & Gynecology Science2005 · 제48권 제11호임신성 당뇨병의 당 부하 검사에 대한 임상적 고찰최범, 김동진, 김정석, 오은희, 윤은미, 이상혁, 최영미대한산부인과학회 · Obstetrics & Gynecology Science2003 · 제46권 제5호당뇨병 임신 발생율 증가에 따른 국가모자보건학적 대책김희숙한국모자보건학회 · 한국모자보건학회지2014 · 제18권 제1호
이 간행물의 다른 논문 (12건)
배양된 쥐의 대식세포에서 프로스타글란딘 또는 산화질소 합성효소 억제제의 투여가 세균 내독소 자극에 의한 adrenomedullin 생산에 미치는 영향서대식, 원혜성, 조용균, 김암, 이필량, 구본상pp. 1468-1475재발성 또는 지속성 상피성 난소암에서의 Docetaxel 요법의 효용성 및 독성김종혁, 김용만, 남주현, 김민균, 김유진, 김대연, 서대식, 김영탁, 주다혜pp. 1476-1484원발성 자궁경부 악성 림프종 6예 임상고찰안준우, 남주현, 최가원, 유항조, 권용순, 공건영, 한애라, 김영탁, 김용만pp. 1485-1492이종이식 PEOH 세포주에서 clusterin에 대한 shRNA의 paclitaxel 내성 효과신은영, 정인철, 박동춘, 최주혁pp. 1493-1498배아 이식에서 임신율에 영향을 주는 요소들: 다변인 분석차병헌, 박은주, 박원일, 서은지, 이진용, 안창숙, 구지선, 홍유경pp. 1499-1507
